OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
OncClub: Join the Chat on Trending Trials in CancerComplimentary print subscription for home or office deliveryIn-person and virtual events just for HCPsLively expert panel discussions featuring peer-to-peer exchangesSubscribe to our eNewsletter for breaking news and curated content
Specialty
View MoreBreast CancerCAR T-cell TherapyChronic Lymphocytic LeukemiaGastrointestinal CancerGenitourinary CancersGynecologic OncologyImmuno-OncologyLung CancerMelanoma & Skin CancerMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • OncClub: Join the Chat on Trending Trials in Cancer
  • Complimentary print subscription for home or office delivery
  • In-person and virtual events just for HCPs
  • Lively expert panel discussions featuring peer-to-peer exchanges
  • Subscribe to our eNewsletter for breaking news and curated content
SpecialtySee All >
  • Breast Cancer
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Shifting Paradigms in Ovarian Cancer

EP. 1: Risk-Reducing Surgery in Epithelial Ovarian Cancer

April 29th 2019

EP. 2: Ovarian Cancer: Neoadjuvant Chemo Vs Primary Debulking

April 29th 2019

EP. 3: Secondary Debulking Surgery in Ovarian Cancer

April 29th 2019

EP. 4: Current Role of VEGF-Targeted Therapy in Ovarian Cancer

April 29th 2019

EP. 5: SOLO-1 and PARP Inhibitors in Ovarian Cancer

April 29th 2019

EP. 6: Detecting Somatic BRCA1/2 Mutations in Ovarian Cancer

April 29th 2019

EP. 7: PARP + Maintenance Bevacizumab in Ovarian Cancer

April 29th 2019

EP. 8: Approaching Platinum-Sensitive Recurrent Ovarian Cancer

April 29th 2019

EP. 9: Ovarian Cancer: Selecting Between Available PARPs

April 29th 2019

EP. 10: Ovarian Cancer: Predictors of PARP Sensitivity

April 29th 2019

EP. 11: PARP Inhibitors in Ovarian Cancer: Safety Profile

April 29th 2019

EP. 12: Ovarian Cancer: Recurrence After PARP Inhibition

April 29th 2019

EP. 13: Rationale for Immunotherapy in Ovarian Cancer

April 29th 2019

EP. 14: I/O Combination Strategies in Ovarian Cancer

April 29th 2019

EP. 15: Ongoing Research in Ovarian Cancer

April 29th 2019

EP. 16: Outlook in Treating Patients With Ovarian Cancer

April 29th 2019